secwatch.observer — SEC 8-K summary
======================================

Issuer:     Penumbra Inc (PEN)
CIK:        0001321732
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001321732-21-000106
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Penumbra Q3 revenue $190.1M (+26%), swings to operating profit; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $190.1M, +25.8% YoY (+25.6% constant currency); US 71%, international 29%.
- Vascular segment $105.5M (+40.3%); Neuro segment $84.7M (+11.5%).
- Gross margin 63.1% vs 60.2%; operating income $8.8M vs loss of $20.2M a year ago.
- Full-year 2021 revenue guidance raised to $735M-$740M from prior $720M-$730M.
- R&D expense fell to $16.7M from $34.9M; SG&A rose to $94.4M from $76.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321732/000132173221000106/0001321732-21-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321732/000132173221000106/pen-20211103.htm
  HTML page:      https://secwatch.observer/filing/0001321732-21-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer